September 6, 2018, – ContextVision is making their second appearance in the field of digital pathology at ECP 2018, the 30th European Congress of Pathology, September 8–12 in Bilbao, Spain. Here, they will be introducing and demonstrating their upcoming product INIFY™ Prostate, a new decision support tool based on artificial intelligence and deep learning.
ContextVision recently made their first appearance in the field of digital pathology at ECDP/NDP 2018 – the 14th European Congress on Digital Pathology and the 5th Nordic Symposium on Digital Pathology, held in Helsinki, Finland, end of May.
ContextVision will attend the 30th European Congress of Pathology (ECP 2018) in Bilbao, Spain. Come and talk to our representatives about our upcoming digital pathology portfolio. Stand 43, hall I + II on level -2 in the Euskalduna Conference Centre
Anna MacDonald, Science Writer for Technology Networks, writes about ContextVision's recent participation in the 5th Nordic Symposium on Digital Pathology, ECDP in Helsinki, where they introduced their upcoming AI product, INIFY™ Prostate.
Keith Loira writes about the rapidly growing market for handheld ultrasound devices in the June edition of Radiology Today. In this article Ann-Sofie Hoff, marketing and product manager at ContextVision, gives her view on how small ultrasound devices can be of great benefit to both clinicians and their patients.